Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm

BACKGROUND: Four randomized controlled trials have demonstrated the short-term efficacy and safety of transoral esophagogastric fundoplication (TF) performed with the EsophyX(®) device in eliminating troublesome gastroesophageal reflux disease (GERD) symptoms in well-selected patient populations. Th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Surg Endosc
Päätekijät: Trad, Karim S., Fox, Mark A., Simoni, Gilbert, Shughoury, Ahmad B., Mavrelis, Peter G., Raza, Mamoon, Heise, Jeffrey A., Barnes, William E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5443856/
https://ncbi.nlm.nih.gov/pubmed/27655380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00464-016-5252-8
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia